Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

TherapeuticsMD Company Profile (NASDAQ:TXMD)

Consensus Ratings for TherapeuticsMD (NASDAQ:TXMD) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.00 (47.68% upside)

Analysts' Ratings History for TherapeuticsMD (NASDAQ:TXMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/28/2014Noble FinancialReiterated RatingBuy$7.25 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Noble FinancialReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/8/2014Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
11/1/2013Stifel NicolausInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
4/26/2013Jefferies GroupInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013Noble FinancialInitiated CoverageBuy$5.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/16/2012 forward)